The management of neurogenic arthropathy: a tale of two charcots.
The pathogenesis and natural history of Charcot neuroarthropathy is often poorly understood. The diagnosis and treatment of Charcot feet can also prove difficult. Two case histories are used to illustrate the key points in the management of this potentially devastating condition.
Young
M J
MJ
Department of Diabetes, Royal Infirmary of Edinburgh, Lauriston Place, Edinburgh EH3 9YW, Scotland, UK.
D000328:Adult; D019386:Alendronate / Q000627:therapeutic use; D000671:Amputation, Surgical; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001177:Arthropathy, Neurogenic / Q000175:diagnosis* / Q000000981:diagnostic imaging / Q000628:therapy; D001186:Artificial Limbs; D001831:Body Temperature; D003922:Diabetes Mellitus, Type 1 / Q000150:complications*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications*; D004164:Diphosphonates; D004487:Edema; D005260:Female; D005528:Foot; D006801:Humans; D008297:Male; D008875:Middle Aged; D000077268:Pamidronate; D011859:Radiography
D000893:Anti-Inflammatory Agents; D004164:Diphosphonates; D000077268:Pamidronate; D019386:Alendronate